IL145719A0 - Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof - Google Patents

Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof

Info

Publication number
IL145719A0
IL145719A0 IL14571900A IL14571900A IL145719A0 IL 145719 A0 IL145719 A0 IL 145719A0 IL 14571900 A IL14571900 A IL 14571900A IL 14571900 A IL14571900 A IL 14571900A IL 145719 A0 IL145719 A0 IL 145719A0
Authority
IL
Israel
Prior art keywords
nucleotide sequences
tumor tissue
breast tumor
polypeptides encoded
sequences expressed
Prior art date
Application number
IL14571900A
Other languages
English (en)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/289,198 external-priority patent/US6586570B1/en
Priority claimed from US09/429,755 external-priority patent/US6656480B2/en
Priority claimed from US09/534,825 external-priority patent/US6861506B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of IL145719A0 publication Critical patent/IL145719A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14571900A 1999-04-09 2000-04-07 Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof IL145719A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/289,198 US6586570B1 (en) 1996-01-11 1999-04-09 Compositions and methods for the treatment and diagnosis of breast cancer
US09/429,755 US6656480B2 (en) 1996-01-11 1999-10-28 Compositions and methods for the treatment and diagnosis of breast cancer
US09/534,825 US6861506B1 (en) 1996-01-11 2000-03-23 Compositions and methods for the treatment and diagnosis of breast cancer
PCT/US2000/009312 WO2000061753A2 (en) 1999-04-09 2000-04-07 Compositions and methods for the treatment and diagnosis of breast cancer

Publications (1)

Publication Number Publication Date
IL145719A0 true IL145719A0 (en) 2002-07-25

Family

ID=27403868

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14571900A IL145719A0 (en) 1999-04-09 2000-04-07 Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof

Country Status (15)

Country Link
EP (1) EP1169444A2 (cs)
JP (1) JP2002541803A (cs)
KR (1) KR20020026418A (cs)
CN (1) CN1352683A (cs)
AU (1) AU774824B2 (cs)
BR (1) BR0009573A (cs)
CA (1) CA2365909A1 (cs)
CZ (1) CZ20013575A3 (cs)
HU (1) HUP0200825A2 (cs)
IL (1) IL145719A0 (cs)
MX (1) MXPA01010186A (cs)
NO (1) NO20014805L (cs)
NZ (1) NZ514646A (cs)
PL (1) PL350863A1 (cs)
WO (1) WO2000061753A2 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US20020068285A1 (en) * 1996-01-11 2002-06-06 Frudakis Tony N. Compositions and methods for the therapy and diagnosis of breast cancer
US20030125536A1 (en) * 1996-01-11 2003-07-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
CN111983220B (zh) * 2019-05-21 2024-03-19 北京中科纳泰生物科技有限公司 多肽磁性纳米颗粒、其制备方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1575697A (en) * 1996-01-10 1997-08-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of cancer
EP1876241A3 (en) * 1996-01-11 2008-07-30 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
AU758004B2 (en) * 1997-12-17 2003-03-13 Genset S.A. Extended cDNAs for secreted proteins
CZ2001149A3 (cs) * 1998-07-14 2002-02-13 Corixa Corporation Prostředky a způsoby pro terapii a diagnostiku karcinomu prostaty

Also Published As

Publication number Publication date
CN1352683A (zh) 2002-06-05
AU4213000A (en) 2000-11-14
EP1169444A2 (en) 2002-01-09
HUP0200825A2 (en) 2002-07-29
NO20014805L (no) 2001-12-06
BR0009573A (pt) 2002-04-16
CZ20013575A3 (cs) 2002-10-16
CA2365909A1 (en) 2000-10-19
JP2002541803A (ja) 2002-12-10
NO20014805D0 (no) 2001-10-03
PL350863A1 (en) 2003-02-10
NZ514646A (en) 2005-04-29
KR20020026418A (ko) 2002-04-10
WO2000061753A2 (en) 2000-10-19
MXPA01010186A (es) 2004-08-12
WO2000061753A3 (en) 2001-06-28
AU774824B2 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
AU3619400A (en) Human prostate cancer associated gene sequences and polypeptides
EP1076090A3 (en) ESTs and encoded human proteins
EP1076090A2 (en) ESTs and encoded human proteins
AU7680300A (en) Human dna sequences
EP1330543A4 (en) IN CANCER TISSUE, EXPRESSED NUCLEIC ACID SEQUENCES DIFFERENTIATE
GB0021259D0 (en) Water treatment
MXPA02011517A (es) Uso de vectores de baculovirus en terapia genetica.
EP1531848A4 (en) DIFFERENTIAL EXPRESSED GENE IN BREAST AND BLADDER CANCER AND CODED POLYPEPTIDE
IL206604A0 (en) Transmembrane protein expressed in prostate cancer
IL145676A0 (en) Tumor necrosis factor homologs and nucleic acids encoding the same
IL145719A0 (en) Polypeptides encoded by nucleotide sequences expressed in breast tumor tissue and uses thereof
EP1210416A4 (en) GENES CODING PROTEINS FOR DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC USE
EP1141301A4 (en) DNA FRAGMENTS DETERMINED ACCORDING TO THEIR SEQUENCE AND CORRESPONDING POLYPEPTIDES CODED BY SAID FRAGMENTS
HK1042504A1 (en) Human cervical cancer 1 protooncogene and protein encoded therein
AU2890199A (en) Gata-3-expression in human breast carcinoma
IL152847A0 (en) Polypeptides containing at least a portion of a breast tumor protein, polynucleotides encoding the same and diagnostic methods utilizing the same
EP1148238A4 (en) SEMI-SPHERICAL SHOE
AU2003228431A8 (en) Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells
EP1148236A4 (en) HALF BALL SHOE
EP1401494A4 (en) TUMOR THERAPY
GB9929694D0 (en) Water treatment
AU2003279100A8 (en) Peptide nucleic acids having improved uptake and tissue distribution
EP1194534A4 (en) NOVEL GENES ENCODING PROTEINS THAT CAN BE USED IN DIAGNOSTIC, PREVENTIVE, THERAPEUTIC OR OTHER AREAS
NZ513739A (en) Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer
GB9903805D0 (en) Pluripotential cells-1